HealthcareServices

Diabetes Diagnostics Market Forecast 2026: Where the Industry Is Headed

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the diabetes diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Diabetes Diagnostics Market?

The diabetes diagnostics market has demonstrated robust growth in recent years. It is projected to increase from $27.31 billion in 2025 to $29.39 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed historically can be attributed to factors such as the rising incidence of diabetes, the widespread use of fingerstick blood glucose testing, the development of hospital-based diagnostic services, enhanced awareness regarding glycemic control, and the growth in diagnostic laboratories.

The diabetes diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $38.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period can be attributed to factors such as the increased utilization of continuous glucose monitoring, the growing acceptance of homecare diagnostic solutions, advancements in biosensor technology, a rise in healthcare spending, and the expansion of digital health ecosystems. Key trends expected during this period involve the broader adoption of continuous glucose monitoring, the incorporation of smart and interconnected diagnostic instruments, a heightened demand for at-home diabetes testing, an amplified emphasis on early diabetes screening initiatives, and progress in non-invasive glucose monitoring methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

What Drivers Are Supporting Technological Adoption In The Diabetes Diagnostics Market?

The rising incidence of obesity is projected to fuel the expansion of the diabetes diagnostics market in the future. Obesity is characterized by an excessive accumulation of body fat, which elevates the risk of various health problems, including heart disease and diabetes. The increased occurrence of obesity is linked to factors such as inactive lifestyles, higher consumption of processed and calorie-dense foods, genetic predispositions, and inadequate physical activity. Diabetes diagnostics assist in obesity management by enabling early identification of insulin resistance and issues with glucose metabolism, thereby allowing for timely interventions to prevent further weight gain and related health complications. For example, in May 2025, the Office for Health Improvement and Disparities, a UK-based government body, reported that an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity from 2023 to 2024, representing an increase from 64.0% in 2022 to 2023. Thus, the increasing prevalence of obesity is propelling the growth of the diabetes diagnostics market.

What Segment Types Are Examined In The Diabetes Diagnostics Market?

The diabetes diagnostics market covered in this report is segmented –

1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

2) By Diabetes Type: Diabetes I, Diabetes Ii, Gestational Diabetes

3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-Enabled Blood Glucose Meters

2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

3) By Lancets: Single-Use Lancets, Multi-Use Lancets

4) By Test Strips: Standard Test Strips, Smart Test Strips

5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

Which Trends Are Expected To Influence The Diabetes Diagnostics Market In The Upcoming Years?

Leading firms within the diabetes diagnostics sector are concentrating on creating advanced offerings like gestational diabetes diagnostics tools. This strategy aims to broaden their product range and address the increasing need for prompt diagnosis and intervention for diabetes during pregnancy. A gestational diabetes diagnostic tool encompasses medical equipment or examinations employed to identify and track gestational diabetes in expectant mothers. These often include blood glucose tests, such as the oral glucose tolerance test (OGTT), which evaluate the body’s sugar processing efficiency during gestation. As an illustration, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit. This innovative biosensor tool is engineered to detect conditions linked to insulin resistance, including gestational diabetes, endometriosis, and liver disease. The kit offers quick results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with existing clinical analyzers. This advancement seeks to provide early diagnostic capabilities, potentially enhancing the prognosis for millions of individuals globally.

Who Are The Primary Competitors In The Global Diabetes Diagnostics Market?

Major companies operating in the diabetes diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medtronic plc, DexCom Inc, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp, Bionime Corporation, Acon Laboratories Inc, Sinocare Inc, i-SENS Inc, Prodigy Diabetes Care LLC, Rossmax International Ltd, Menarini Diagnostics s.r.l, Trividia Health Inc, EKF Diagnostics Holdings plc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Diabetes Diagnostics Market?

North America was the largest region in the diabetes diagnostics market in 2025. The regions covered in the diabetes diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Diabetes Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2026, By The Business Research Company

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Digital Diabetes Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Point Of Care Glucose Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795